Hba1C and T1 Tech. It matters.
T1 Tech is critical for helping PWT1D to manage their condition and et better ot
Blog Posts
The CGM Royal Rumble – 4 systems face off, one will win…
Back in early October the CGM Royal Rumble kicked off. Four CGM systems, located in their manufacturer recommended locations on the body and using their […]
#FreeStyleLibre2 – further thoughts
The big question that remains for many more technical users in relation to the FreeStyle Libre 2 is whether it is transmitting glucose data or […]
Abbott’s #FreestyleLibre2. Announced today at #EASD2018 – more questions than answers…
Abbott’s Freestyle Libre 2. Newly announced at EASD2018. Introducing bluetooth connectivity and real-time alarms.
#Libre – An example of ongoing variance within Diabetes care, looking at London area where this wasn’t supposed to happen…
A review of the variation across London in prescribing Libre.
Comparing Tandem’s Basal-IQ to Medtronic’s SmartGuard. Which Predictive Low Glucose Suspend is best?
If you’ve been looking at Diabetes technology recently, it’s hard not to have seen the recent news from Tandem about rolling out their Predictive Low […]
When we talk about complications, we need to talk about “Risk” #TalkAboutComplications
It’s hard not to have seen the recent Twitter and blog campaign that came about as the result of Grumpy Pumper’s diagnosis of a foot […]
#DIYAPS use in the UK – A Snapshot
In the UK, at least 82 people (as of the date of publishing) are using DIY APS systems to manage their diabetes. Of these, the majority are using AndroidAPS.
Fiasp and the Onset 5 CSII Trial – What Novo Nordisk found
Around the time of launching Fiasp, Novo Nordisk embarked on a wider study of its use in Continuous Subcutaneous Insulin Infusion (CSII), or pumping as […]
Nemaura Sugarbeat’s interim home trial results. Are they any good?
Over the past eight months, Nemaura have announced a number of outcomes of their clinical trials, all of which have suggested that after a tricky […]